Browse > Article

Suppression of Arsenic Trioxide-induced Apoptosis in HeLa Cells by N-Acetylcysteine  

Han, Yong Hwan (Department of Physiology, Medical School, Institute for Medical Sciences, Center for Healthcare Technology Development, Chonbuk National University)
Kim, Sung Zoo (Department of Physiology, Medical School, Institute for Medical Sciences, Center for Healthcare Technology Development, Chonbuk National University)
Kim, Suhn Hee (Department of Physiology, Medical School, Institute for Medical Sciences, Center for Healthcare Technology Development, Chonbuk National University)
Park, Woo Hyun (Department of Physiology, Medical School, Institute for Medical Sciences, Center for Healthcare Technology Development, Chonbuk National University)
Abstract
Arsenic trioxide (ATO) can affect many biological functions such as apoptosis and differentiation in various cells. We investigated the involvement of ROS and GSH in ATO-induced HeLa cell death using ROS scavengers, especially N-acetylcysteine (NAC). ATO increased intracellular ${O_2}^{{\cdot}-}$ levels and reduced intracellular GSH content. The ROS scavengers, Tempol, Tiron and Trimetazidine, did not significantly reduce levels of ROS or GSH depletion in ATO-treated HeLa cells. Nor did they reduce the apoptosis induced by ATO. In contrast, treatment with NAC reduced ROS levels and GSH depletion in the ATO-treated HeLa cells and prevented ATO-induced apoptosis. Treatment with exogenous SOD and catalase reduced the depletion of GSH content in ATO-treated cells. Catalase strongly protected the cells from ATO-induced apoptosis. In addition, treatment with SOD, catalase and NAC slightly inhibited the G1 phase accumulation induced by ATO. In conclusion, NAC protects HeLa cells from apoptosis induced by ATO by up-regulating intracellular GSH content and partially reducing the production of ${O_2}^{{\cdot}-}$.
Keywords
apoptosis; arsenic trioxide; GSH; HeLa; ROS; ROS scavenger;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 8  (Related Records In Web of Science)
연도 인용수 순위
1 Cuzzocrea, S., McDonald, M.C., Mazzon, E., Siriwardena, D., Costantino, G., Fulia, F., Cucinotta, G., Gitto, E., Cordaro, S., Barberi, I., et al. (2000). Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury. Brain Res.875, 96-106   DOI   ScienceOn
2 Han, S.S., Kim, K., Hahm, E.R., Park, C.H., Kimler, B.F., Lee, S.J., Lee, S.H., Kim, W.S., Jung, C.W., Park, K., et alK (2005). Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J. Cell. Biochem. 94, 695-707   DOI   ScienceOn
3 Li, J.J., Tang, Q., Li, Y., Hu, B.R., Ming, Z.Y., Fu, Q., Qian, J.Q., and Xiang, J.Z. (2006). Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta. Pharmacol. Sin.27, 1078-1084   DOI   ScienceOn
4 Park, W.H., Jung, C.W., Park, J.O., Kim, K., Kim, W.S., Im, Y.H., Lee, M.H., Kang, W.K., and Park, K. (2003). Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. Int. J. Oncol. 22, 1129-1134
5 Poot, M., Teubert, H., Rabinovitch, P.S., and Kavanagh, T.J. (1995). De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J. Cell. Physiol. 163, 555-560   DOI   ScienceOn
6 Tikhaze, A.K., Lankin, V.Z., Zharova, E.A., and Kolycheva, S.V. (2000). Trimetazidine as indirect antioxidant. Bull. Exp. Biol. Med. 130, 951-953
7 Wallach-Dayan, S.B., Izbicki, G., Cohen, P.Y., Gerstl-Golan, R., Fine, A., and Breuer, R. (2006). Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L790-L796   DOI   ScienceOn
8 Woo, S.H., Park, I.C., Park, M.J., Lee, H.C., Lee, S.J., Chun, Y.J., Lee, S.H., Hong, S.I., and Rhee, C.H. (2002). Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Int. J. Oncol. 21, 57-63
9 Wu, X.X., Ogawa, O., and Kakehi, Y. (2004). Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. Int. J. Oncol.24, 1489-1497
10 Zhang, W., Ohnishi, K., Shigeno, K., Fujisawa, S., Naito, K., Nakamura, S., Takeshita, K., Takeshita, A., and Ohno, R. (1998). The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 12, 1383-1391   DOI
11 Zorov, D.B., Juhaszova, M., and Sollott, S.J. (2006). Mitochondrial ROS-induced ROS release: An update and review. Biochem. Biophys. Acta. 1757, 509-517   DOI   ScienceOn
12 Han, Y.H., Kim, S.Z., Kim, S.H., and Park, W.H. (2007). Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am. J. Physiol. Renal. Physiol. 293, F511-520   DOI   ScienceOn
13 Bubici, C., Papa, S., Pham, C.G., Zazzeroni, F., and Franzoso, G. (2006). The NF-kappaB-mediated control of ROS and JNK signaling. Histol. Histopathol.21, 69-80
14 Hyun Park, W., Hee Cho, Y., Won Jung, C., Oh Park, J., Kim, K., Hyuck Im, Y., Lee, M.H., Ki Kang, W., and Park, K. (2003). Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem. Biophys. Res. Commun. 300, 230-235   DOI   ScienceOn
15 Khan, N.S., Ahmad, A., and Hadi, S.M. (2000). Anti-oxidant, prooxidant properties of tannic acid and its binding to DNA. Chem. Biol. Interact. 125, 177-189   DOI   ScienceOn
16 Shim, H.Y., Park, J.H., Paik, H.D., Nah, S.Y., Kim, D.S., and Han, Y.S. (2007). Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondriamediated death signaling and SAPK/JNK1/2-c-Jun activation. Mol. Cells 24, 95-104
17 Yamada, J., Yoshimura, S., Yamakawa, H., Sawada, M., Nakagawa, M., Hara, S., Kaku, Y., Iwama, T., Naganawa, T., Banno, Y. et alK (2003). Cell permeable ROS scavengers, Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/ reoxygenation. Neurosci. Res.45, 1-8   DOI   ScienceOn
18 Han, Y.H., Kim, S.Z., Kim, S.H., and Park, W.H. (2008b). Intracellular GSH level is a factor in As4.1 juxtaglomerular cell death by arsenic trioxide. J. Cell. Biochem. 104, 995-1009   DOI   ScienceOn
19 Kito, M., Akao, Y., Ohishi, N., Yagi, K., and Nozawa, Y. (2002). Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 291, 861-867   DOI   ScienceOn
20 Dai, J., Weinberg, R.S., Waxman, S., and Jing, Y. (1999). Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93, 268-277
21 Han, Y.H., Kim, S.H., Kim, S.Z., and Park, W.H. (2008a). Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels. J. Cell. Biochem. 104, 862-878   DOI   ScienceOn
22 Macho, A., Hirsch, T., Marzo, I., Marchetti, P., Dallaporta, B., Susin, S.A., Zamzami, N., and Kroemer, G. (1997). Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J. Immunol.158, 4612-4619
23 Scott, N., Hatlelid, K.M., MacKenzie, N.E., and Carter, D.E. (1993). Reactions of arsenic(III) and arsenic(V) species with glutathione. Chem. Res. Toxicol. 6, 102-106   DOI   ScienceOn
24 Zhang, T.C., Cao, E.H., Li, J.F., Ma, W., and Qin, J.F. (1999). Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur. J. Cancer 35, 1258-1263   DOI   ScienceOn
25 Baj, G., Arnulfo, A., Deaglio, S., Mallone, R., Vigone, A., De Cesaris, M.G., Surico, N., Malavasi, F., and Ferrero, E. (2002). Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. Breast Cancer Res. Treat. 73, 61-73   DOI   ScienceOn
26 Dasmahapatra, G., Rahmani, M., Dent, P., and Grant, S. (2006). The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood 107, 232-240   DOI   ScienceOn
27 Kim, H.R., Kim, E.J., Yang, S.H., Jeong, E.T., Park, C., Kim, S.J., Youn, M.J., So, H.S., and Park, R. (2006). Combination treatment with arsenic trioxide and sulindac augments their apoptotic potential in lung cancer cells through activation of caspase cascade and mitochondrial dysfunction. Int. J. Oncol. 28, 1401-1408
28 Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwar, S., Calleja, E., Dardashti, L.J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D.A.I et al. (1998). Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339, 1341-1348   DOI   ScienceOn
29 Li, M., Cai, J.F., and Chiu, J.F. (2002). Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells. J. Cell. Biochem. 87, 29-38   DOI   ScienceOn
30 Nakagawa, Y., Akao, Y., Morikawa, H., Hirata, I., Katsu, K., Naoe, T., Ohishi, N., and Yagi, K. (2002). Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. Life Sci. 70, 2253-2269   DOI   ScienceOn
31 Simon, H.U., Haj-Yehia, A., and Levi-Schaffer, F. (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418   DOI   ScienceOn
32 Uslu, R., Sanli, U.A., Sezgin, C., Karabulut, B., Terzioglu, E., Omay, S.B., and Goker, E. (2000). Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin. Cancer Res.6, 4957-4964
33 Oketani, M., Kohara, K., Tuvdendorj, D., Ishitsuka, K., Komorizono, Y., Ishibashi, K., and Arima, T. (2002). Inhibition by arsenic trioxide of human hepatoma cell growth. Cancer Lett. 183, 147-153   DOI   ScienceOn
34 Baran, C.P., Zeigler, M.M., Tridandapani, S., and Marsh, C.B. (2004). The role of ROS and RNS in regulating life and death of blood monocytes. Curr. Pharm. Des.10, 855-866   DOI   ScienceOn
35 Chen, T.J., Jeng, J.Y., Lin, C.W., Wu, C.Y., and Chen, Y.C. (2006). Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells. Toxicology 223, 113-126   DOI   ScienceOn
36 Jing, Y., Dai, J., Chalmers-Redman, R.M., Tatton, W.G., and Waxman, S. (1999). Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxidedependent pathway. Blood 94, 2102-2111
37 Park, W.H., Seol, J.G., Kim, E.S., Hyun, J.M., Jung, C.W., Lee, C.C., Kim, B.K., and Lee, Y.Y. (2000). Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res. 60, 3065-3071
38 Maeda, H., Hori, S., Ohizumi, H., Segawa, T., Kakehi, Y., Ogawa, O., and Kakizuka, A. (2004). Effective treatment of advanced solid tumors by the combination of arsenic trioxide and Lbuthionine- sulfoximine. Cell Death Differ.11, 737-746   DOI   ScienceOn
39 Lauterburg, B.H. (2002). Analgesics and glutathione. Am. J. Ther. 9, 225-233   DOI   ScienceOn
40 Wilcox, C.S. (2002). Reactive oxygen species: roles in blood pressure and kidney function. Curr. Hypertens Rep.4, 160-166   DOI   ScienceOn
41 Schnelldorfer, T., Gansauge, S., Gansauge, F., Schlosser, S., Beger, H.G., and Nussler, A.K. (2000). Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89, 1440-1447   DOI   ScienceOn
42 Shen, Z.Y., Shen, W.Y., Chen, M.H., Shen, J., and Zeng, Y. (2003). Reactive oxygen species and antioxidants in apoptosis of esophageal cancer cells induced by As2O3. Int. J. Mol. Med.11, 479-484
43 Greenstock, C.L., and Miller, R.W. (1975). The oxidation of tiron by superoxide anion. Kinetics of the reaction in aqueous solution in chloroplasts. Biochim. Biophys. Acta. 396, 11-16   DOI   ScienceOn
44 Kitamura, K., Minami, Y., Yamamoto, K., Akao, Y., Kiyoi, H., Saito, H., and Naoe, T. (2000). Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 14, 1743-1750   DOI
45 Seol, J.G., Park, W.H., Kim, E.S., Jung, C.W., Hyun, J.M., Kim, B.K., and Lee, Y.Y. (1999). Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem. Biophys. Res. Commun. 256, 400-404
46 Gonzalez, C., Sanz-Alfayate, G., Agapito, M.T., Gomez-Nino, A., Rocher, A., and Obeso, A. (2002). Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respir. Physiol. Neurobiol. 132, 17-41   DOI   ScienceOn
47 Hedley, D.W., and Chow, S. (1994). Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 15, 349-358   DOI   ScienceOn
48 Haga, N., Fujita, N., and Tsuruo, T. (2005). Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells. Cancer science 96, 825-833   DOI   ScienceOn
49 Wang, Z.G., Rivi, R., Delva, L., Konig, A., Scheinberg, D.A., Gambacorti- Passerini, C., Gabrilove, J.L., Warrell, R.P., Jr., and Pandolfi, P.P. (1998). Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Blood 92, 1497-1504
50 Miller, W.H., Jr., Schipper, H.M., Lee, J.S., Singer, J., and Waxman, S. (2002). Mechanisms of action of arsenic trioxide. Cancer Res. 62, 3893-3903
51 Stanley, W.C., and Marzilli, M. (2003). Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine. Fundam. Clin. Pharmacol. 17, 133-145   DOI   ScienceOn
52 Pu, Y.S., Hour, T.C., Chen, J., Huang, C.Y., Guan, J.Y., and Lu, S.H. (2002). Cytotoxicity of arsenic trioxide to transitional carcinoma cells. Urology 60, 346-350   DOI   ScienceOn
53 Kang, Y.H., Yi, M.J., Kim, M.J., Park, M.T., Bae, S., Kang, C.M., Cho, C.K., Park, I.C., Park, M.J., Rhee, C.H.I et alK (2004). Caspase- independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADPribose polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 64, 8960-8967   DOI   ScienceOn